The contribution of combined crystalloid and colloid osmosis to fluid and sodium management in peritoneal dialysis

Kidney International

Volumn 73, Issue SUPPL. 108, 2008, Pages

  Freida, P ^a,e   Wilkie, M ^b   Jenkins, S ^b   Dallas, F ^c   Issad, B ^d  

^a Louis Pasteur Hospital   (France)

^b SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c CUMBERLAND INFIRMARY   (United Kingdom)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e Department of Nephrology   (France)

Author keywords

Combination dialysate; Glucose; Icodextrin; Ultrafiltration

Indexed keywords

GLUCOSE; GLUCOSE POLYMER; ICODEXTRIN; SODIUM; CRYSTALLOID SOLUTIONS; DIALYSIS FLUID; GLUCAN; ISOTONIC SOLUTION;

CAPILLARY FLOW; CLINICAL TRIAL; COLLOID; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CRYSTALLOID; FLUID BALANCE; HUMAN; OSMOSIS; PERITONEAL DIALYSIS; PRIORITY JOURNAL; REVIEW; ULTRAFILTRATION; ELECTROLYTE BALANCE; METABOLISM; METHODOLOGY; PHYSIOLOGY;

COLLOIDS; DIALYSIS SOLUTIONS; GLUCANS; GLUCOSE; HUMANS; ISOTONIC SOLUTIONS; OSMOSIS; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; SODIUM; WATER-ELECTROLYTE BALANCE;

EID: 44449120504     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002610     Document Type: Article

References (28)

1. Paniagua R, Amato D, Vonesh E et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002; 13: 1307-1320.
2. Davies SJ, Brown EA, Reigel W et al. What is the link between poor ultrafiltration and increased mortality in anuric patients on automated peritoneal dialysis? Analysis of data from EAPOS. Perit Dial Int 2006; 26: 458-465.
3. Davies SJ. Optimizing automated peritoneal dialysis: increasing nightly dialysate flow vs adding a manual daytime exchange. Nat Clin Pract Nephrol 2007; 3: 248-249.
4. Davies SJ. Mitigating peritoneal membrane characteristics in modern peritoneal dialysis therapy. Kidney Int 2006; 70(Suppl 103): S76-S83.
5. Demetriou D, Habicht A, Schillinger M et al. Adequacy of automated peritoneal dialysis with and without manual daytime exchange: a randomized controlled trial. Kidney Int 2006; 70: 1649-1655.
6. Rippe B, Levin L. Computer simulations of ultrafiltration profiles for an icodextrin-based peritoneal fluid in CAPD. Kidney Int 2000; 57: 2546-2556.
7. Wilkie M. Icodextrin - what about the fractions? Perit Dial Int 2005; 25: 161-162.
8. Peers EM. Icodextrin plus glucose combinations for use in CAPD. Perit Dial Int 1997; 17(Suppl 2): S68-S69.
9. Mistry CD, Gokal R, Peers E. A randomized multicenter clinical trial comparing isoosmolar icodextrin with hyperosmolar glucose solution in CAPD. Kidney Int 1994; 46: 496-503.
10. Mistry CD, Gokal R. Optimal use of glucose polymer (icodextrin) in peritoneal dialysis. Perit Dial Int 1996; 16(Suppl 1): S104-S108.
11. Faller B, Shockley T, Genestier S, Martis L. Polyglucose and amino acids: preliminary results. Perit Dial Int 1997; 17(Suppl 2): S63-S67.
12. Jenkins SB, Wilkie ME. An exploratory study of a novel peritoneal combination dialysate (1.36% glucose/7.5% icodextrin), demonstrating improved ultrafiltration compared to either component studied alone. Perit Dial Int 2003; 23: 475-480.
13. Dallas F, Jenkins SB, Wilkie ME. Enhanced ultrafiltration using 7.5% icodextrin/1.36% glucose combination dialysate: a pilot study. Perit Dial Int 2004; 24: 542-546.
14. Freida P, Galach M, Divino Filho JC et al. Combination of crystalloid (glucose) and colloid (icodextrin) osmotic agents markedly enhances peritoneal fluid and solute transport during the long PD dwell. Perit Dial Int 2007; 27: 267-276.
15. Rippe B. A three-pore model of peritoneal transport. Perit Dial Int 1993; 13(Suppl 1): S35-S38.
16. Wieslander A, Lindén T. Glucose degradation and cytotoxicity in PD fluids. Perit Dial Int 1996; 16(Suppl 1): S114-S118.
17. Dobbie J. Advanced glycosylation end products in peritoneal tissue with different solutions. Perit Dial Int 1997; 17(Suppl 2): S27-S30.
18. Dawney A. Advanced glycation end products in peritoneal dialysis. Perit Dial Int 1996; 16(Suppl 1): S50-S53.
19. Honda K, Nitta K, Horita S et al. Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration. Nephrol Dial Transplant 1999; 14: 1541-1549.
20. Smeby LC, Wideröe T-E, Mjaaland S, Dahl K. Changes in ultrafiltration and solute transport during CAPD. In: Maher JF, Winchester JF (eds). Frontiers in Peritoneal Dialysis. Field, Rich and Associates: New York, 1986 pp 68-74.
21. Holmes C, Mujais S. Glucose sparing in peritoneal dialysis: implications and metrics. Kidney Int 2006; 70(Suppl 103): S104-S109.
22. Rodriguez-Carmona A, Perez Fontan M, Garcia Lopez E et al. Use of icodextrin during nocturnal automated peritoneal dialysis allows sustained ultrafiltration while reducing the peritoneal glucose load: a randomized crossover study. Perit Dial Int 2007; 27: 260-266.
23. Jenkins S, Wilkie M. Commentaries. Mixing osmotic agents - two different approaches. Perit Dial Int 2007; 27: 245-250.
24. Vonesh EF, Lysaght MJ, Moran J, Farrell P. Kinetic modelling as a prescription aid in peritoneal dialysis. Blood Purif 1991; 9: 246-270.
25. Vonesh EF, Keshaviah PR. Applications in kinetic modelling using PD Adequest. Perit Dial Int 1997; 17(Suppl 2): S119-S125.
26. Pecoits-Filho R, Mujais S, Lindholm B. Future of icodextrin as an osmotic agent in peritoneal dialysis. Kidney Int 2002; 62(Suppl 81): S80-S87.
27. Krediet R, Douma C, Ho-dac-Pannekeet M et al. Impact of different dialysis solutions on solute and water transport. Perit Dial Int 1997; 17(Suppl 2): S17-S26.
28. Ho-Dac-Pannekeet MM, Schouten N, Langendijk MJ et al. Peritoneal transport characteristics with glucose polymer based dialysate. Kidney Int 1996; 50: 979-986.